An alternative treatment for hypervascular hepatocellular carcinoma
Monday, June 15, 2009 - 15:49
in Health & Medicine
HCC is the fifth most common cancer in the world and the third most frequent cause of cancer-related death. Only about 20% of HCC patients are eligible for surgical resection. Therefore, RFA has been used increasingly as a safe technique for treating hepatic tumours. However, for hypervascular HCC, RFA appears less effective because of its blood-flow-induced heat sink effect, which might cause incomplete ablation or recurrence...